Triple
T4662442
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biological Sciences Division, University of Chicago |
E102564
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
Committee on Development, Regeneration and Stem Cell Biology
The Committee on Development, Regeneration and Stem Cell Biology is an academic program at the University of Chicago focused on research and graduate training in developmental biology, tissue regeneration, and stem cell science.
|
E458589
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee on Development, Regeneration and Stem Cell Biology | Statement: [Biological Sciences Division, University of Chicago, hasPart, Committee on Development, Regeneration and Stem Cell Biology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Committee on Development, Regeneration and Stem Cell Biology Context triple: [Biological Sciences Division, University of Chicago, hasPart, Committee on Development, Regeneration and Stem Cell Biology]
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
Division of Genetics and Development
The Division of Genetics and Development is a research unit within the National Institute for Medical Research focused on understanding genetic mechanisms and developmental processes in health and disease.
-
E.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Committee on Development, Regeneration and Stem Cell Biology Triple: [Biological Sciences Division, University of Chicago, hasPart, Committee on Development, Regeneration and Stem Cell Biology]
Generated description
The Committee on Development, Regeneration and Stem Cell Biology is an academic program at the University of Chicago focused on research and graduate training in developmental biology, tissue regeneration, and stem cell science.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Committee on Development, Regeneration and Stem Cell Biology Target entity description: The Committee on Development, Regeneration and Stem Cell Biology is an academic program at the University of Chicago focused on research and graduate training in developmental biology, tissue regeneration, and stem cell science.
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
Division of Genetics and Development
The Division of Genetics and Development is a research unit within the National Institute for Medical Research focused on understanding genetic mechanisms and developmental processes in health and disease.
-
E.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43d823288190952279faa0d1d066 |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd632b7fb88190821f213620719d6b |
completed | March 20, 2026, 3:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bdfafcd3908190aabf7975017ce337 |
completed | March 21, 2026, 1:57 a.m. |
| NEDg | Description generation | batch_69bdfc7b84108190af39c7780f702745 |
completed | March 21, 2026, 2:03 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69bdfd3856b48190a44f49da5fde38f6 |
completed | March 21, 2026, 2:06 a.m. |
Created at: March 20, 2026, 1:15 p.m.